SonoRx

SonoRx®

Simethicone-coated cellulose suspension Imaging A gas-shadowing reduction agent used to enhance delineation of upper abdominal anatomy with ultrasound imaging
References in periodicals archive ?
Both LumenHance and SonoRx have finished Phase III clinical trials in the U.
Bristol-Myers Squibb Company had previously acquired the North American rights to SonoRx through a separate in-licensing agreement with ImaRx Pharmaceutical Corp.
SonoRx represents a new class of diagnostic imaging products that may be used by a broad range of medical practitioners who perform abdominal ultrasound procedures.
He added, "We believe that SonoRx will satisfy a currently unmet clinical demand for more reliable depiction of gastrointestinal anatomy when using ultrasound techniques.
March 8 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) today announced that it has acquired the United States rights to manufacture and market a new oral ultrasound contrast agent under the trade name SonoRx (R) (cellulose, simethicone coated).
We elected to license SonoRx to Squibb Diagnostics for several reasons, including Bristol-Myers Squibb Company's worldwide presence and leadership position in the pharmaceutical industry and their commitment to exploring the cutting edge of ultrasound technology.
Bristol-Myers Squibb Company will submit an Investigational New Drug (IND) application for SonoRx in 1993.